Product Information

HYDROCODONE-IBUPROFEN 7.5-200 is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.4854 per EA under NDC 53746014501. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Mar 18, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

HYDROCODONE-IBUPROFEN 7.5-200

Hydrocodone Bitartrate and Ibuprofen
$0.4854per EA
DEA Schedule CII

Strength

7.5; 200 mg/1; mg/1

NDC

53746014501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA076642

FDA Approved

3/18/2004

TE Code

AB

On Market Since

2/18/2010

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug
Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-IBUPROFEN 7.5-200 has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 116.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4854 per EA
All-time high$0.4891 (May 13, 2026)
All-time low$0.1692 (Jun 22, 2022)
52-week high$0.4891
52-week low$0.4767
Median price$0.2855
Average price$0.3220
Largest weekly change+34.3% (Feb 18, 2015)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+0.0%

1M

+0.0%

3M

-0.4%

6M

-0.4%

1Y

+0.6%

3Y

+0.6%

5Y

+156.3%

All

+116.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of HYDROCODONE-IBUPROFEN 7.5-200?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-IBUPROFEN 7.5-200, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.4854 per EA (NDC 53746014501), effective Aug 19, 2026.

How has the price of HYDROCODONE-IBUPROFEN 7.5-200 changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-IBUPROFEN 7.5-200 has risen 116.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-IBUPROFEN 7.5-200?

Since Nov 28, 2013, the NADAC for HYDROCODONE-IBUPROFEN 7.5-200 has ranged from a low of $0.1692 (Jun 22, 2022) to a high of $0.4891 (May 13, 2026), with a median of $0.2855 per EA.

Are there cheaper alternatives to HYDROCODONE-IBUPROFEN 7.5-200?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as HYDROCODONE-IBUPROFEN 7.5-200 in a comparable dosage form, but none are currently priced below it.

Who manufactures HYDROCODONE-IBUPROFEN 7.5-200?

HYDROCODONE-IBUPROFEN 7.5-200 (NDC 53746014501) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.